Shareholders who wish to recommend or nominate director candidates must provide information about themselves and their candidates and comply with procedures and timelines contained in our Bylaws. These procedures are described under “Shareholder Proposals or Nominations” in this Proxy Statement.

Board diversity is critical to the success of the Company. Our Corporate Governance Principles reflect the Board’s commitment to ensuring itsa diverse membership has sufficient diversity of experience,with varied experiences, skills and personal characteristics to support the long-term success of the Company. As presently constituted, the Board represents a deliberate mix of members who have a deep understanding of our business, as well as members who have different skill sets and points of view.perspectives. Therefore, the NCGC’s evaluation of director nominees includes consideration of candidates who bring a diversity ofcandidates’ professional experiences and personal background,backgrounds, including review of characteristics such as age, gender, race and ethnicity.

West has a long-standing commitment to diversityDiversity, Equity and inclusionInclusion (“D&I”DEI”), which is inherent in our Core Valuecore value of One West Team. We are in the business ofcommitted to helping our customers bring new medicines and treatments that advance life—life for peoplepatients who represent all dimensions of every background, race and belief.diversity. Our purpose is an important reminder that we must continue to listen and learn from one another with safe and inclusive environments to create the path to a better future.

The Board has overseenoversees and encouragedencourages Management’s efforts to bolster the D&IDEI efforts across the Company. For example, West’s Chief Executive Officer and executive leadership team review D&IDEI objectives throughout the year to ensure continuous focus and improvement. Today, 30%33% of West’s elected Officers are women, with 60% beingand 67% are women and/or people of color. West has made great strides over the past several years in sourcing team members from diverse backgrounds for leadership roles across the organization. As of December 31, 2021,Company-wide, 43% of our senior leaders were women and/or minorities.

The Board recognizesacknowledges its role in overseeing the Company’s culture and in holding Management accountable for the creation and stewardship of a culture that values D&I. One of the Company’s top priorities is buildingDEI. Building a diverse and inclusive workforce where team members are respected and feel confident in bringing their unique ideas to the table.table is a top priority and one of our six ESG priorities. The Company understands that to helpattract and retain talented team members, we must continue embedding D&I strategies across the entireproviding exceptional employee experience. Some of these programs includeexperiences for all team members, including during the onboarding of new team members, in our recruiting materials, management training, succession planning, affirmative action plans, recruitment materialsglobal mentoring and global mentoring.our employee engagement survey. To foster transparency and continued growth in this area, the Company will publishpublishes its annual Consolidated EEO-1 Report with respect to 2020 and beyondReports on its website, www.westpharma.comwww.westpharma.com/about-west/corporate-responsibility.

Board Refreshment and Retirement Age

We are committed to board refreshment and have added fourthree new directors over the past sixfour years. These additions are the result of a thoughtful process designed to ensure an effective balance of historical perspective and an understanding of the evolution of our business with fresh viewpoints and insights.

The Board believes that a diverse mix of long tenuredlong-tenured and new Board members provides a good and appropriate balance of experience to enhance shareholder value. The Board believes that directors provide meaningful, independent oversight and advice at any age. Our Corporate Governance Principles include a retirement age of 75. This means that a non-employee director generally